Compare EDIT & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDIT | LOVE |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0M | 193.2M |
| IPO Year | 2016 | 2018 |
| Metric | EDIT | LOVE |
|---|---|---|
| Price | $2.44 | $10.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.92 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 1.7M | 170.9K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $31,937,000.00 | ★ $680,628,000.00 |
| Revenue This Year | N/A | $3.68 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $0.91 | $10.50 |
| 52 Week High | $4.54 | $21.90 |
| Indicator | EDIT | LOVE |
|---|---|---|
| Relative Strength Index (RSI) | 58.88 | 25.85 |
| Support Level | $2.42 | N/A |
| Resistance Level | $2.76 | $13.76 |
| Average True Range (ATR) | 0.20 | 0.48 |
| MACD | 0.06 | -0.19 |
| Stochastic Oscillator | 65.08 | 6.73 |
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.